By G HossainPosted on June 4, 2026Posted in Pharmaceutical & Bio Science, UncategorizedTagged bio science career, blogs, business career news, career tips, job blog, job news, RJF Pharmaceutical Jobs Parabilis Medicines is joining the parade of biotechs going public, sharing plans to raise as much as $476.4 million to help advance its lead cancer candidate into late-stage testing. Peptide biotech Parabilis targets up to $476M IPO Post navigation Alnylam hops on AI train with up to $2B Inceptive partnershipLilly and Boehringer roll back billions in German investments over health budget cuts